Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Perindopril
Active Ingredient: Perindopril erbumine 2mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturers: Apotex Inc, Ontario, Canada
Apotex Research Private Limited, Bangalore, India
Product: Apo-Perindopril
Active Ingredient: Perindopril erbumine 4mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturers: Apotex Inc, Ontario, Canada
Apotex Research Private Limited, Bangalore, India
Product: Apo-Perindopril
Active Ingredient: Perindopril erbumine 8mg
Dosage Form: Tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturers: Apotex Inc, Ontario, Canada
Apotex Research Private Limited, Bangalore, India
Product: Ibuprofen Softgel (Pharmacy Only)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Liquid filled capsule
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Marksans Pharma Limited, Goa, India
Product: Ibuprofen Softgel (General Sale)
Active Ingredient: Ibuprofen 200mg
Dosage Form: Liquid filled capsule
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Marksans Pharma Limited, Goa, India
Dated this 15th day of November 2012.
DR PAT TUOHY, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).